Clinical Pharmacokinetics and Pharmacodynamics of Dalcetrapib

por Black, Donald M., Bentley, Darren, Chapel, Sunny, Lee, Jongtae, Briggs, Emily, Heinonen, Therese
Publicado 2018

Dalcetrapib Reduces Risk of New-Onset Diabetes in Patients With Coronary Heart Disease

por Schwartz, Gregory G., Leiter, Lawrence A., Ballantyne, Christie M., Barter, Philip J., Black, Donald M., Kallend, David, Laghrissi-Thode, Fouzia, Leitersdorf, Eran, McMurray, John J.V., Nicholls, Stephen J., Olsson, Anders G., Preiss, David, Shah, Prediman K., Tardif, Jean-Claude, Kittelson, John
Publicado 2020

Pharmacogenetics-guided dalcetrapib therapy after an acute coronary syndrome: the dal-GenE trial( )

por Tardif, Jean Claude, Pfeffer, Marc A, Kouz, Simon, Koenig, Wolfgang, Maggioni, Aldo P, McMurray, John J V, Mooser, Vincent, Waters, David D, Grégoire, Jean C, L’Allier, Philippe L, Wouter Jukema, J, White, Harvey D., Heinonen, Therese, Black, Donald M, Laghrissi-Thode, Fouzia, Levesque, Sylvie, Guertin, Marie Claude, Dubé, Marie Pierre
Publicado 2022